These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32987193)

  • 1. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
    Lacout A; Marcy PY; Perronne C
    Clin Microbiol Infect; 2021 Jan; 27(1):134-135. PubMed ID: 32987193
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
    Million M; Roussel Y; Lagier JC; Raoult D
    Clin Microbiol Infect; 2021 Jan; 27(1):132-133. PubMed ID: 32980527
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
    Vedrines N; Bouthors AT; Gayet S; Lacout A
    Clin Microbiol Infect; 2021 Jun; 27(6):918-919. PubMed ID: 33129929
    [No Abstract]   [Full Text] [Related]  

  • 4. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
    Molina JM; Delaugerre C; Le Goff J; Mela-Lima B; Ponscarme D; Goldwirt L; de Castro N
    Med Mal Infect; 2020 Jun; 50(4):384. PubMed ID: 32240719
    [No Abstract]   [Full Text] [Related]  

  • 5. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
    Sivapalan P; Ulrik CS; Lappere TS; Eklöf JV; Shaker SB; Bødtger UCS; Browatzki A; Meyer CN; Weinreich UM; Laursen CB; Biering-Sørensen T; Knop FK; Lundgren JD; Jensen JS
    Trials; 2020 Oct; 21(1):867. PubMed ID: 33081817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.
    Ramireddy A; Chugh H; Reinier K; Ebinger J; Park E; Thompson M; Cingolani E; Cheng S; Marban E; Albert CM; Chugh SS
    J Am Heart Assoc; 2020 Jun; 9(12):e017144. PubMed ID: 32463348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.
    Saleh M; Gabriels J; Chang D; Soo Kim B; Mansoor A; Mahmood E; Makker P; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Chinitz J; Skipitaris N; Mountantonakis S; Epstein LM
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008662. PubMed ID: 32347743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
    Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
    Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
    Gautret P; Hoang VT; Honoré S; Roussel Y; Million M; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106241. PubMed ID: 33408031
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
    Gautret P; Lagier JC; Parola P; Hoang VT; Meddeb L; Sevestre J; Mailhe M; Doudier B; Aubry C; Amrane S; Seng P; Hocquart M; Eldin C; Finance J; Vieira VE; Tissot-Dupont HT; Honoré S; Stein A; Million M; Colson P; La Scola B; Veit V; Jacquier A; Deharo JC; Drancourt M; Fournier PE; Rolain JM; Brouqui P; Raoult D
    Travel Med Infect Dis; 2020; 34():101663. PubMed ID: 32289548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does hydroxychloroquine reduce mortality for COVID-19?
    Gallus S; Clavenna A; Lugo A
    Eur J Intern Med; 2020 Dec; 82():21-22. PubMed ID: 33127218
    [No Abstract]   [Full Text] [Related]  

  • 13. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
    Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
    Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine + azithromycin treatment in elderly patients.
    Gautret P; Ly TDA; Raoult D
    Int J Antimicrob Agents; 2021 Apr; 57(4):106313. PubMed ID: 33716178
    [No Abstract]   [Full Text] [Related]  

  • 16. Audio Interview: Studying Potential Covid-19 Therapies.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
    [No Abstract]   [Full Text] [Related]  

  • 17. A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality.
    Fernández-Cruz A; Ruiz-Antorán B; Muñoz-Gómez A; Sancho-López A; Mills-Sánchez P; Centeno-Soto GA; Blanco-Alonso S; Javaloyes-Garachana L; Galán-Gómez A; Valencia-Alijo Á; Gómez-Irusta J; Payares-Herrera C; Morrás-Torre I; Sánchez-Chica E; Delgado-Téllez-de-Cepeda L; Callejas-Díaz A; Ramos-Martínez A; Múñez-Rubio E; Avendaño-Solá C
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute meningoencephalitis in a patient with COVID-19.
    Chaumont H; Etienne P; Roze E; Couratier C; Roger PM; Lannuzel A
    Rev Neurol (Paris); 2020 Jun; 176(6):519-521. PubMed ID: 32414534
    [No Abstract]   [Full Text] [Related]  

  • 19. Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence.
    Bigna JJ; Kamtchum-Tatuene J; Noubiap JJ
    Travel Med Infect Dis; 2020; 38():101886. PubMed ID: 32980540
    [No Abstract]   [Full Text] [Related]  

  • 20. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
    Alizargar J
    Travel Med Infect Dis; 2020; 38():101881. PubMed ID: 32956851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.